Publications

Home > Publications > A Visual Representation of the Observational Study of Extended Adjuvant Neratinib in HER2+ Early Breast Cancer in the Context of the European Early Access Program (EAP): NEAR Study Final Results

A Visual Representation of the Observational Study of Extended Adjuvant Neratinib in HER2+ Early Breast Cancer in the Context of the European Early Access Program (EAP): NEAR Study Final Results

Oncology Other poster
Auteurs : T. Silovski, A. Cano Jimenez, M. Križić, N. Dedić Plavetić, X. González Farre, A. Guerrero Zotano, F. Beghdad, O. Dialla, M. Zivanov, O. Romano, G. Hoste, M. De Laurentiis
Date de publication : 21 November 2024
Go to the publication
string(132) "background-color: #003da5;-webkit-border-radius: 40%; -moz-border-radius: 40%; border-radius: 40%;opacity: 1;right:20px;bottom:75px;"